research
Sarah is a PhD Candidate at the InsideOut Institute and Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney. She holds a Bachelors in Chemistry from the University of Birmingham, UK and a Masters in Neuroimaging from King’s College London, UK. She has always been fascinated with neuropsychopharmacology and aims to explore novel pharmacotherapies to improve available treatments for eating disorders. As part of her PhD, she will be investigating cannabidiol, a non-psychoactive compound from the cannabis plant, in children and adolescents with anorexia nervosa. She will also be investigating psilocybin, known colloquially as magic mushrooms, in adults with treatment-resistant anorexia nervosa. She hopes that these novel interventions will be effective adjuncts to psychotherapy to help individuals with anorexia nervosa along varying stages of illness progression.
This study explores the use of cannabidiol (CBD) as an adjunct to treatment for people with Anorexia Nervosa (AN).
This study explored the experience of prescription and non-prescription drug use in people with eating disorders. Findings indicate that the perceived health benefits of substances like psychedelics and cannabis often rating more favourably than conventional prescription medication.
This trial evaluates the safety, feasibility, and preliminary efficacy of psilocybin-assisted psychotherapy for individuals with treatment-resistant anorexia nervosa who have not responded to standard evidence-based interventions.
© 2026 InsideOut
InsideOut acknowledges the tradition of custodianship and law of the Country on which the University of Sydney and Charles Perkins Centre campus stands. We pay our respects to those who have cared and continue to care for Country. We are committed to diversifying research and eliminating inequities and discrimination in healthcare. We welcome all people regardless of age, gender, race, size, sexuality, language, socioeconomic status, location or ability.